| Literature DB >> 19015892 |
Ria Blaauwbroek1, Martijn J Bouma, Wemke Tuinier, Klaas H Groenier, Matthieu H G de Greef, Betty Meyboom-de Jong, Willem A Kamps, Aleida Postma.
Abstract
OBJECTIVE: The aim of this study was to evaluate the results of home-based exercise counselling with feedback from a pedometer on fatigue in adult survivors of childhood cancer. PATIENTS: Adult survivors of childhood cancer were recruited from the long-term follow-up clinic of the University Medical Centre Groningen, The Netherlands. A score of 70 mm on a visual analogue scale (scale, 0-100 mm) for fatigue was used as an inclusion criterion. Controls were recruited by the survivors among their healthy siblings or peers.Entities:
Mesh:
Year: 2008 PMID: 19015892 PMCID: PMC2707951 DOI: 10.1007/s00520-008-0533-y
Source DB: PubMed Journal: Support Care Cancer ISSN: 0941-4355 Impact factor: 3.603
Fig. 1Study design. CIS Checklist Individual Strength
Topics discussed by the counsellor at the start of the study
| 1 | How the pedometer works |
| 2 | How to record the daily steps and other daily physical activity on the specially developed website or in the diary |
| 3 | An information leaflet on how to increase daily physical activity and develop a physically active lifestyle |
| 4 | Participants were asked to use a pedometer for 2 weeks maintaining their normal daily physical activities as usual, and record their steps in a diary on the website or by posted diaries. Baseline step monitoring was used to assess baseline daily physical activity |
| 5 | Participants were asked to complete a CIS questionnaire and to find a relative or friend who would also be willing to complete this questionnaire at three different moments during the study |
| 6 | Participants were shown how to keep in contact with the counsellor by e-mail or telephone |
Characteristics of the participants
| Participants ( | |
|---|---|
| Age (years)a | 29.8 ± 8,6 |
| Age at diagnosis (years)a | 8.1 ± 6.7 |
| Time since diagnosisa | 21.8 ± 7.1 |
| Male genderb | 14 (30.4) |
| Diagnosisb | |
| Leukemia | 22 (46.8) |
| Malignant lymphoma | 6 (12.8) |
| Bone tumour | 4 (8.5) |
| Soft tissue sarcoma | 3 (6.4) |
| Wilms’ tumour | 1 (2.1) |
| Langerhans cell histiocytosis | 2 (4.3) |
| CNS tumour | 6 (12.8) |
| Other | 3 (6.4) |
| Treatmentb | |
| Chemotherapy only | 22 (47.8) |
| Surgery only | 2 (4.4) |
| Radiotherapy only | 0 (0) |
| Chemo and radiotherapy | 22 (47.8) |
| Cranial radiation | 12 (26.1) |
aMedian ± SD
bNumber (percentage)
Fig. 2Changes in CIS scores in survivors and controls during study period. CIS Checklist Individual Strength; lines connect mean CIS scores, vertical bars represent 95% CI. Mean CIS scores ± SD of participants (81.42 ± 20.14 at T1; 62.62 ± 20.86 at T10; 63.67 ± 23.12 at T 36) and controls (47.39 ± 19.06 at T1; 46.18 ± 17.70 at T10; 42.57 ± 17.40 at T36)
Fig. 3Increase in number of steps of survivors during study period (lines connect means, error bars represent 95% CI). Mean steps ± SD of survivors(7.653 ± 3.272 at T0; 10.168 ± 3.483 at T3; 11.803 ± 3.695 at T10)